| Autor: |
White, E. Lucile, Southworth, Kristen, Ross, Larry, Cooley, Sara, Gill, Rachel B., Sosa, Melinda Ingrum, Manouvakhova, Anna, Rasmussen, Lynn, Goulding, Celia, Eisenberg, David, Fletcher, Thomas M. |
| Zdroj: |
SLAS Discovery: Advancing Life Sciences R&D; February 2007, Vol. 12 Issue: 1 p100-105, 6p |
| Abstrakt: |
Pantothenate synthetase (PS; EC 6.3.2.1), encoded by the panCgene, catalyzes the essential adenosine triphosphate (ATP)–dependent condensation of D-pantoate and β-alanine to form pantothenate in bacteria, yeast, and plants; pantothenate is a key precursor for the biosynthesis of coenzyme A (CoA) and acyl carrier protein (ACP). Because the enzyme is absent in mammals and both CoA and ACP are essential cofactors for bacterial growth, PS is an attractive chemotherapeutic target. An automated high-throughput screen was developed to identify drugs that inhibit Mycobacterium tuberculosisPS. The activity of PS was measured spectrophotometrically through an enzymatic cascade involving myokinase, pyruvate kinase, and lactate dehydrogenase. The rate of PS ATP utilization was quantitated by the reduction of absorbance due to the oxidation of NADH to NAD+by lactate dehydrogenase, which allowed for an internal control to detect interference from compounds that absorb at 340 nm. This coupled enzymatic reaction was used to screen 4080 compounds in a 96-well format. This discussion describes a novel inhibitor of PS that exhibits potential as an antimicrobial agent. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
